rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

OrthoPediatrics Corp.

KIDS · Nasdaq

Health CareMedical DevicesLeading

KIDS stood above a rising 150-day average in 20 of the last 52 weekly readings, including each of the last 20 weeks. It is 11.6% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
20 in a row
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$95.5M
Officials’ trades on record
2
Institutions holding
113 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 20 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$49.0M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

2 disclosed lines: House 2, Senate 0, executive 0; 1 people.

WhoDidAmountTraded
Greg Gianforte House: U.S. House ClerkMT00bought$15k–$50k18 Jun 2020filed 25 Jun 2020
Greg Gianforte House: U.S. House ClerkMT00bought$50k–$100k15 Jan 2020filed 14 Feb 2020

Insiders

Buy orders, 12 months0
Sale orders, 12 months32
Buyers · sellers0 · 9
WhoDidSharesTraded
Jennifer N. Pritzker10% ownersold302,369at $21.0110 Sep 2026filed 11 Sep 2026
Squadron Capital Llc10% ownersold302,369at $21.0110 Sep 2026filed 11 Sep 2026
David R. PelizzonDirector, 10% ownersold302,369at $21.0110 Sep 2026filed 10 Sep 2026
Jennifer N. Pritzker10% ownersold22,500at $23.352 Sep 2026filed 4 Sep 2026
Squadron Capital Llc10% ownersold22,500at $23.352 Sep 2026filed 4 Sep 2026
David R. PelizzonDirector, 10% ownersold22,500at $23.352 Sep 2026filed 4 Sep 2026
Jennifer N. Pritzker10% ownersold10,131at $23.101 Sep 2026filed 1 Sep 2026
Squadron Capital Llc10% ownersold10,131at $23.101 Sep 2026filed 1 Sep 2026
David R. PelizzonDirector, 10% ownersold10,131at $23.101 Sep 2026filed 1 Sep 2026
Jennifer N. Pritzker10% ownersold326,700at $23.0428 Aug 2026filed 1 Sep 2026
Squadron Capital Llc10% ownersold326,700at $23.0428 Aug 2026filed 1 Sep 2026
David R. PelizzonDirector, 10% ownersold326,700at $23.0428 Aug 2026filed 1 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders113+2 on the quarter
New · exited19 · 17
Reported value$313.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BROWN ADVISORY INCadded · filed 14 Aug 20261,678,983$32.1M+160,965+10.6%
BlackRock, Inc.added · filed 7 Aug 20261,272,714$24.3M+98,668+8.4%
BRAIDWELL LPunchanged · filed 14 Aug 20261,100,370$21.1M00.0%
Granahan Investment Management, LLCadded · filed 14 Aug 20261,085,964$20.8M+189,223+21.1%
MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 2026816,830$15.6M-420,069−34.0%
WELLINGTON MANAGEMENT GROUP LLPreduced · filed 14 Aug 2026794,309$15.2M-93,135−10.5%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026755,624$14.5M+37,448+5.2%
Soleus Capital Management, L.P.added · filed 11 Aug 2026732,144$14.0M+116,697+19.0%
MORGAN STANLEYreduced · filed 13 Aug 2026693,387$13.3M-447,731−39.2%
WASATCH ADVISORS LPadded · filed 10 Jul 2026515,677$9.9M+186,357+56.6%
31 Mar 2023 – 30 Jun 2026
99107114Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

David R. Pelizzon Company insiderDirector, 10% owner · last 10 Sep 20265 · 7
Jennifer N. Pritzker Company insider10% owner · last 10 Sep 20264 · 7
Squadron Capital Holdings Llc Company insider10% owner · last 10 Sep 20260 · 6
Squadron Capital LLC Company insider10% owner · last 10 Sep 20260 · 7
(Reynolds) Marie C. Infante Company insiderDirector · last 9 Jun 20260 · 2
Bryan W. Hughes Company insiderDirector · last 9 Jun 20260 · 0
David R. Bailey Company insiderPresident and CEO · last 9 Jun 20260 · 9
George Sinclair Mitchell Dyer Company insiderDirector · last 9 Jun 20260 · 0
Harold Ruf Company insiderDirector · last 9 Jun 20263 · 0
Jimmy Duane McDonald Company insiderDirector · last 9 Jun 20260 · 0
Kelly Laine Fischer Company insiderDirector · last 9 Jun 20260 · 0
Mark C. Throdahl Company insiderDirector · last 9 Jun 20260 · 12

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202573.1%
Operating profit marginFY 2025 · to 31 Dec 2025-16.6%
Free cash flow marginFY 2025 · to 31 Dec 2025-6.8%
Return on capital employedFY 2025 · to 31 Dec 2025-8.5%
Debt to equityFY 2025 · to 31 Dec 20250.31×
Research spendFY 2025 · to 31 Dec 20253.9%
Share count trendFY 2025 · to 28 Feb 20260.7%
Cash and equivalentsFY 2025 · to 31 Dec 2025$19.6M
Free cash flowFY 2025 · to 31 Dec 2025−$16.0M

Analyst forecasts

No analyst forecasts yet.